NYSE: $HAE In the rapidly evolving field of cardiac electrophysiology, the precision of venous access closure is as critical as the primary procedure itself. Haemonetics Corporation recently announced compelling new clinical evidence regarding its VASCADE MVP® XL venous vascular closure system, marking a significant milestone for procedural safety and efficiency in large-bore venous access. The…